Rezultati pretraživanja
  1. prije 8 sati

    Understanding Fortress Biotech: Daniel Carlson of Tailwinds Research takes a close look at what he calls a "great value opportunity," with a focus on subsidiary Avenue Therapeutics.

  2. prije 24 sata

    - almost to time to eject before FDA news

    Prikaži ovu nit
  3. 1. velj

    -$0.29 EPS Expected for Avenue Therapeutics Inc This Quarter

  4. 1. velj

    Zacks: Brokerages Anticipate Avenue Therapeutics Inc Will Announce Earnings of -$0.29 Per Share

  5. 1. velj

    Major changes in stock price 3.27 % change recently

  6. 31. sij

    considerable price movement -3.29 % change recently

  7. 30. sij

    exactly don't sell -2.93 % change recently

  8. 29. sij

    close. Volume too low for my liking so far.

  9. 29. sij

    Avenue Therapeutics Inc Short Interest Down 25.8% in January

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.